North America Urinary Tract Infections Market was worth USD 1.83 billion in 2016 and estimated to be growing at a CAGR of 2.04%, to reach USD 2.03 billion by 2021. A urinary tract infection is an infection which affects parts of the urinary tract. When it affects the lower urinary tract it is called as a bladder infection or cystitis and when it affects the upper urinary tract it is called kidney infection or pyelonephritis. Symptoms from a lower urinary tract include frequent urination, pain with urination, and feeling the need to urinate in spite of having an empty bladder. Symptoms of a kidney infection include flank pain and fever usually in addition to the symptoms of a lower urinary tract infection. The urine may appear bloody in rare cases. In the very young and the very old, symptoms may be non-specific or vague.
View full report @ http://www.marketdataforecast.com/market-reports/north-america-urinary-tract-infections-market-4548/
The driving factors of North America urinary tract infections market are sudden rise in the prevalence rate and the diagnosis for the disease. This has started the opportunities for major players to allocate their resources towards research and development of a combination therapy. This will surely result in the growth of market size during the forecast period. With the launch of new drugs for multiple indications under urinary tract infections, and label expansion for drugs which are already existing, the market is expected to boost further. The generic, low cost competition for some of the drugs is fierce and is forecasted to get more competitive and thus can contribute to offsetting of the figures for current market size.
Get free sample report @ http://www.marketdataforecast.com/market-reports/north-america-urinary-tract-infections-market-4548/request-sample

Inquire before buying @ http://www.marketdataforecast.com/market-reports/north-america-urinary-tract-infections-market-4548/inquire
The North America Urinary Tract Infections market is divided based on geography into United States, Canada and Mexico. North America has the third largest market in the world for urinary tract infections by share. In the North America region, United States has the largest market share, while Canada is expected to grow at the fastest rate. Factors such as increasing geriatric population and growing disposable incomes are expected to propel the market growth in the region.
Urinary Tract Infections Industry key players are Pfizer, Inc., AstraZeneca plc, Johnson & Johnson, Novartis International AG., F. Hoffmann La Roche Ltd., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, and Cipla Ltd., among others.
Market Segmentation
1)Type of Medication
• Penicillin & Combinations
• AmoxicillinAmoxicillin-Clavulanate Potassium combination
• Quinolones
• Ciprofloxacin
• Levofloxacin
• Norfloxacin
• Nalidixic Acid

2)Aminoglycoside-Antibodies
• Gentamicin
• Amikacin
• Cephalosporin
• Ceftriaxone
• Cefixime
• Cefuroxime
• Cephalexin

3)Sulphonamides
• Sulfamethoxazol
• Trimethoprim combination
• Azoles & Amphotericin B
• Tetracycline
• Doxycycline
• Nitrofurans
• Nitrofurans
• Y-o-Y Growth Analysis, By Type of Medication
• Market Attractiveness Analysis, By Type of Medication
• Market Share Analysis, By Type of Medication

4) Type of Indication
• Uncomplicated UTI
• Complicated UTI
• Recurring Complicated UTI
• Neurogenic Bladder Infection
• Y-o-Y Growth Analysis, By Type of Indication
• Market Attractiveness Analysis, By Type of Indication
• Market Share Analysis, By Type of Indication

Buy now @ http://www.marketdataforecast.com/cart/buy-now/north-america-urinary-tract-infections-market-4548/